[Focal neuropathies: new possibilities for pharmacological treatment]

An open randomized trial of 58 patients with focal neuropathies of upper extremities has compared the efficacy of neyromidin (ipidacrinum) used in intramuscular injections and by the introduction of local injection perineural therapy. Both methods were combined with the following electroneurostimulation at the peak of drug action (30 min after the injection). The efficacy of treatment was assessed 14 days and 1 month after the end of treatment course by specific questionnaires and scales and an electroneuromyographic study. The data obtained indicate the efficacy of neyromidin in the treatment of patients with focal neuropathies of upper extremities. The introduction of the drug using local injection perineural therapy has demonstrated significantly better results.